Authors

• Geke A.P. Hospers (ORCID: https://orcid.org/0000-0002-3047-7892)
• Wouter V. Vogel (ORCID: https://orcid.org/0000-0002-4992-8024)
• Ronald Boellaard (ORCID: https://orcid.org/0000-0002-0313-5686)
• Filip De Vos (ORCID: https://orcid.org/0000-0002-9082-5991)
• Ellen Kapiteijn (ORCID: https://orcid.org/0000-0002-4814-6426)
• Marcel P. M. Stokkel (ORCID: https://orcid.org/0000-0002-8131-5690)
• Berlinda J. de Wit–van der Veen (ORCID: https://orcid.org/0000-0002-7860-2904)
• Bernies van der Hiel (ORCID: https://orcid.org/0000-0001-8158-405X)
• Maureen J.B. Aarts (ORCID: https://orcid.org/0000-0002-6381-1500)
• John B A G Haanen
• Astrid A M van der Veldt
• Marye J Boers-Sonderen
• Marta Lopez-Yurda
• Jan Willem B. de Groot (ORCID: https://orcid.org/0000-0002-1043-5011)
• Alfons J M van den Eertwegh

Institutions

• University Medical Center Groningen (NL)
• Radboud University Nijmegen (NL)
• Leiden University Medical Center (NL)
• Erasmus MC (NL)
• Radboud University Medical Center (NL)
• The Netherlands Cancer Institute (NL)
• University Medical Center Utrecht (NL)
• Maastricht University (NL)
• Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
• Isala (NL)
• Amsterdam University Medical Centers (NL)
• Vrije Universiteit Amsterdam (NL)

Publication Details

Journal

EJNMMI Research

Published

2025-05-28

DOI

https://doi.org/10.1186/s13550-025-01259-x

Citations

2

Primary Topic

Melanoma and MAPK Pathways

Type

article

Field-Weighted Citation Impact

1.61

Funders

• F. Hoffmann-La Roche